Bruker (FRA:BKD) Total Liabilities: €3,138 Mil (As of Mar. 2026)


FRA:BKD Bruker Corp FRA:BKD
86 GF Score
Price €53.31
GF Value €53.37
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Bruker Total Liabilities?

Bruker FRA:BKD -1.20% 86 Total Liabilities is €3,138 Mil as of Mar. 2026. GuruFocus rates FRA:BKD with a GF Score™ of 86/100 and a GF Value™ of €53.37 (Fairly Valued). The stock has 10 warning signs investors should review.

Bruker's Total Liabilities for the quarter that ended in Mar. 2026 was €3,138 Mil.

Bruker's quarterly Total Liabilities declined from Sep. 2025 (€3,359.01 Mil) to Dec. 2025 (€3,186.36 Mil) and declined from Dec. 2025 (€3,186.36 Mil) to Mar. 2026 (€3,138.13 Mil).

Bruker's annual Total Liabilities increased from Dec. 2023 (€2,601.16 Mil) to Dec. 2024 (€3,811.88 Mil) but then declined from Dec. 2024 (€3,811.88 Mil) to Dec. 2025 (€3,186.36 Mil).

Bruker Total Liabilities Historical Data

* Premium members only.

The historical data trend for Bruker's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Total Liabilities Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,270.20 2,341.12 2,601.16 3,811.88 3,186.36

Bruker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,775.76 3,878.09 3,359.01 3,186.36 3,138.13
FRA:BKD
86GF Score
Bruker Corp FRA:BKD
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bruker Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bruker's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1092.437+(1700.399+204.277
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+189.246+0+0)
=3,186

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=5330.156-2143.796
=3,186

Bruker's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1172.161+(1438.408+527.564
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3,138

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=5303.055-2164.922
=3,138

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €3,138 Mil mean?
Bruker (FRA:BKD) has a Total Liabilities of €3,138 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bruker and its competitors.
Is Bruker's Total Liabilities too high?
Bruker's current Total Liabilities is €3,138 Mil. Overall, Bruker has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's Total Liabilities compare to GKOS and BIO?
Bruker's Total Liabilities of €3,138 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bruker and its competitors. Bruker's current Total Liabilities is €3,138 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €53.37, compared to a current price of €53.31 — trading 0.1% below its estimated fair value. The current Total Liabilities is €3,138 Mil. Bruker's overall GF Score™ is 86/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bruker (FRA:BKD), the current Total Liabilities is €3,138 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (FRA:BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €53.31 is trading 0.1% below its estimated GF Value™ of €53.37. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for FRA:BKD:

  • Total Liabilities: €3,138 Mil
  • GF Value™: €53.37 vs. price of €53.31 (0.1% below fair value)
  • GF Score™: 86/100 with 10 warning signs

No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score

Get the complete analysis for FRA:BKD

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€53.31
Price
€53.37
GF Value